Recent disappointing results for ventricular assist device companies are raising questions over adoption of the technology—which is meant to assist patients’ weakened hearts with pumping blood. HeartMate II, as shown on ...
Thoratec Corp. has replaced CEO Gary Burbach with the man who previously led the company for a decade. New president and CEO Keith Grossman served in those roles at the Pleasanton, CA–based company from 1996 to 2006, when Burbach ...
Thoratec has gained an investigational device exemption(IDE)from the US Food and Drug Administration(FDA)for the initiation of a feasibility clinical study of its continuous-flow left ventricular assist device(LVAD),for the treatment of ...